Establishing cutoff values for visual amyloid positivity in [18F]flutemetamol PET

被引:0
|
作者
Park, Yong-Jin [1 ]
Moon, So Young [2 ]
Yoon, Joon-Kee [1 ]
Lee, Su-Jin [1 ]
An, Young-Sil [1 ,3 ]
机构
[1] Ajou Univ, Dept Nucl Med & Mol Imaging, Sch Med, Suwon, South Korea
[2] Ajou Univ, Dept Neurol, Sch Med, Suwon, South Korea
[3] Ajou Univ, Sch Med, Dept Nucl Med & Mol Imaging, 206 World Cup Ro, Suwon 16499, Gyeonggi Do, South Korea
来源
EJNMMI RESEARCH | 2025年 / 15卷 / 01期
关键词
Amyloid; Positron emission tomography; Flutemetamol; Cutoff; CortexID suite; VALIDATION;
D O I
10.1186/s13550-024-01193-4
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Background This study aimed to establish the optimal cutoff values for visual amyloid positivity using standardized uptake value ratios (SUVRs) in [F-18]flutemetamol (FMM) positron emission tomography (PET) imaging. Given the variability in amyloid assessment, our goal was to determine cutoff values that enhance diagnostic accuracy and assist clinicians in reliably identifying amyloid positivity. Results The identified cutoff values for visual amyloid positivity were > 1.6 for the cerebellar gray matter, > 1.38 for the whole cerebellum, and > 0.63 for the pons, yielding high sensitivity (95.5%, 94.5%, and 95.8%, respectively) and specificity (91.2%, 94.3%, and 95.2%, respectively). Conclusions The SUVR cutoff values demonstrated excellent diagnostic performance, supporting their clinical use in assessing visual amyloid positivity in [F-18]FMM PET imaging.
引用
收藏
页数:7
相关论文
共 50 条
  • [41] Clinical outcomes up to 9 years after [18F]flutemetamol amyloid-PET in a symptomatic memory clinic population
    Collij, Lyduine E.
    Farrar, Gill
    Zwan, Marissa
    van de Giessen, Elsmarieke
    Ossenkoppele, Rik
    Barkhof, Frederik
    Rozemuller, Annemieke J. M.
    Pijnenburg, Yolande A. L.
    van der Flier, Wiesje M.
    Bouwman, Femke
    ALZHEIMERS RESEARCH & THERAPY, 2023, 15 (01)
  • [42] Visual hallucinations in Parkinson's disease and amyloid burden: 18F-Flutemetamol PET-MRI study
    Fernandez-Rodriguez, B.
    Gasca-Salas, C.
    Rodriguez-Rojas, R.
    Guida, P.
    Mata-Marin, D.
    Obeso-Martin, I.
    Vela, L.
    Garcerant-Tafur, M.
    Garcia-Canamaque, L.
    Obeso, J. A.
    MOVEMENT DISORDERS, 2019, 34 : S687 - S687
  • [43] Clinical outcomes up to 9 years after [18F]flutemetamol amyloid-PET in a symptomatic memory clinic population
    Collij, L.
    Farrar, G.
    Zwan, M.
    van de Giessen, E. M.
    Ossenkoppele, R.
    Barkhof, F.
    Rozemuller, A.
    Pijnenburg, Y.
    Van der Flier, W. M.
    Bouwman, F.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2023, 50 (SUPPL 1) : S241 - S241
  • [44] Clinical outcomes up to 9 years after [18F]flutemetamol amyloid-PET in a symptomatic memory clinic population
    Lyduine E. Collij
    Gill Farrar
    Marissa Zwan
    Elsmarieke van de Giessen
    Rik Ossenkoppele
    Frederik Barkhof
    Annemieke J. M. Rozemuller
    Yolande A. L. Pijnenburg
    Wiesje M. van der Flier
    Femke Bouwman
    Alzheimer's Research & Therapy, 15
  • [45] The effect of reduced administered activity and image reconstruction on SUVR quantification in [18F] flutemetamol amyloid PET-MR scanning
    Rodriguez, J. Anton
    Herholz, K.
    Carter, S. F.
    Matthews, J. C.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2021, 48 (SUPPL 1) : S425 - S426
  • [46] [18F]-Flutemetamol PET Amyloid Imaging and Cortical Biopsy Histopathology in Normal Pressure Hydrocephalus: Pooled Analysis of Four Studies
    Wolk, David
    Rinne, Juha
    Wong, Dean
    Leinonen, Ville
    Arnold, Steven
    Buckley, Chris
    Smith, Adrian
    McLain, Richard
    Sherwin, Paul
    Farrar, Gill
    Kailajarvi, Marita
    Grachev, Igor
    NEUROLOGY, 2012, 78
  • [47] Possibility of Shortening Examination Time in Amyloid PET using 18F-Flutemetamol
    Otani, Tamaki
    Otsuka, Hideki
    Matsushita, Kou
    Otomi, Yoichi
    Kunikane, Yamato
    Azane, Shota
    Miyoshi, Hirokazu
    JOURNAL OF NUCLEAR MEDICINE, 2020, 61
  • [48] 18F-Flutemetamol PET/CT for Transthyretin Amyloid Cardiomyopathy Timing Matters
    Han, Eun Ji
    Sung, Yeoun Eun
    Jung, Mi-Hyang
    O, Joo Hyun
    Youn, Jong-Chan
    CLINICAL NUCLEAR MEDICINE, 2022, 47 (12) : 1074 - 1076
  • [49] [18F]-Flutemetamol PET Amyloid Imaging and Cortical Biopsy Histopathology in Normal Pressure Hydrocephalus: Pooled Analysis of Four Studies
    Wolk, David
    Rinne, Juha
    Wong, Dean
    Leinonen, Ville
    Arnold, Steven
    Buckley, Chris
    Smith, Adrian
    McLain, Richard
    Sherwin, Paul
    Farrar, Gill
    Kailajarvi, Marita
    Grachev, Igor
    NEUROLOGY, 2012, 78
  • [50] Clinical significance of focal ß-amyloid deposition measured by 18F-flutemetamol PET
    Si Eun Kim
    Byungju Lee
    Seongbeom Park
    Soo Hyun Cho
    Seung Joo Kim
    Yeshin Kim
    Hyemin Jang
    Jee Hyang Jeong
    Soo Jin Yoon
    Kyung Won Park
    Eun-Joo Kim
    Na Yeon Jung
    Bora Yoon
    Jae-Won Jang
    Jin Yong Hong
    Jihye Hwang
    Duk L. Na
    Sang Won Seo
    Seong Hye Choi
    Hee Jin Kim
    Alzheimer's Research & Therapy, 12